Diagnostic and prognostic utility of plasma thrombospondin-1 levels in traumatic brain injury
European Journal of Trauma and Emergency Surgery · 2024-10 · 50 (5) · 2229-2237
DOI: 10.1007/s00068-024-02605-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Trauma and Emergency Surgery, online erschienen am 07.08.2024. Verfasst von Lei Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Thrombospondin 1, Glasgow Coma Scale, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
PURPOSE: Thrombospondin-1 (TSP-1), a powerful antiangiogenic agent, is increasingly expressed in mice brain tissues after traumatic brain injury (TBI). However, in the peripheral blood of TBI patients, TSP-1 concentrations have not been identified. This study aimed to determine if TSP-1 measured in the plasma of patients relates to TBI diagnosis and injury severity. METHODS: Plasma TSP-1 levels were assessed in 75 patients with mild to severe TBI and 60 healthy volunteers. Glasgow Coma Scale (GCS) score was recorded to assess traumatic severity. Other relevant clinical characters and laboratory tests were collected to evaluate the diagnostic efficiency of TSP-1. Glasgow outcome scale (GOSE) 3 months after trauma was dichotomized into unfavorable (GOSE1-4) and favorable (GOSE5-8) outcomes. RESULTS: TSP-1 levels were significantly higher in TBI patients than in controls (median 530.4 ng/l, the upper- lower quartiles 373.2-782.1 vs. median 201.5 mg/l, the upper - lower quartiles 83.1-351.4, P 624.4 ng/ml independently predicted a 3-month unfavorable outcome with an odds ratio value of 9.666 (95% confidence interval (CI),1.393-69.072). TSP-1 levels significantly discriminated 3-month unfavorable outcome with AUROC of 0.7445 (95%CI, 0.6152-0.8739). CONCLUSION: The results of this study indicate that plasma TSP-1 should be further investigated as a diagnostic and prognostic marker for patients with TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
- Department of Laboratory Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. fanchunmei2023@163.com.
- Department of Neurosurgery, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. xiangrongchen2023@163.com.
Förderung
- Natural Science Foundation of Fujian Province
Zitieren
APA
Liu, L., Huang, R., Fan, C., & Chen, X. (2024). Diagnostic and prognostic utility of plasma thrombospondin-1 levels in traumatic brain injury. European Journal of Trauma and Emergency Surgery, 50(5), 2229-2237. https://doi.org/10.1007/s00068-024-02605-9
Vancouver
Liu L, Huang R, Fan C, Chen X. Diagnostic and prognostic utility of plasma thrombospondin-1 levels in traumatic brain injury. European Journal of Trauma and Emergency Surgery. 2024;50(5):2229-2237. doi:10.1007/s00068-024-02605-9
BibTeX
@article{Liu2024,
author = {Liu, Lei and Huang, Rongfu and Fan, Chunmei and Chen, Xiangrong},
title = {Diagnostic and prognostic utility of plasma thrombospondin-1 levels in traumatic brain injury},
journal = {European Journal of Trauma and Emergency Surgery},
year = {2024},
volume = {50},
number = {5},
pages = {2229--2237},
doi = {10.1007/s00068-024-02605-9}
}
EUVIMED